Single Comprehensive Ultrasound to Rule Out DVT in High-risk Patients
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
|3||Active, not recruiting||
Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma
† Study has passed its completion date and status has not been verified in more than two years.